Jinling Pharmaceutical Company Limited (SHE:000919)
China flag China · Delayed Price · Currency is CNY
7.77
+0.15 (1.97%)
Feb 4, 2026, 3:04 PM CST

SHE:000919 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,2581,7711,5481,4951,5021,316
Short-Term Investments
103.5165.22337.45250--
Trading Asset Securities
1,198706.05233.8692.351.251.38
Cash & Short-Term Investments
2,5602,6422,1191,8371,5031,317
Cash Growth
21.51%24.69%15.33%22.25%14.12%-16.44%
Accounts Receivable
694.77686.73591.05467.22507.2488.79
Other Receivables
7.078.168.7653.1216.856.38
Receivables
701.84694.89599.81520.34524.05495.17
Inventory
267.15271.62290.91250.48245.48215.44
Prepaid Expenses
--0.151.16-4.35
Other Current Assets
15.399.379.6323.7916.2915.13
Total Current Assets
3,5443,6183,0202,6332,2892,047
Property, Plant & Equipment
1,4841,5011,5411,3031,2971,307
Long-Term Investments
60.63431.07369.32265.01638.97674.37
Goodwill
62.4262.42148.7227.3318.0564.01
Other Intangible Assets
322.87325.67341.67258.44140.2148.18
Long-Term Deferred Tax Assets
14.4412.4916.6128.5419.6214.95
Long-Term Deferred Charges
74.9383.3413.9418.2617.854.89
Other Long-Term Assets
460.654.494210.726.9622.9
Total Assets
6,0246,0895,4934,5444,4484,284
Accounts Payable
551.09595.31546.69454.04479.36465.79
Accrued Expenses
70.53212.46224.73219.95207.27164.74
Short-Term Debt
---1.4815.01-
Current Portion of Leases
2.774.233.081.531.06-
Current Income Taxes Payable
57.9435.5337.9748.3843.0936.62
Current Unearned Revenue
26.735.617.6522.1426.930.67
Other Current Liabilities
251.64143.9182.53117.983.25101.75
Total Current Liabilities
960.671,0271,013865.42855.95799.57
Long-Term Debt
150.09150.12----
Long-Term Leases
37.4434.8538.62.290.59-
Long-Term Unearned Revenue
0.7610.470.630.791.27
Long-Term Deferred Tax Liabilities
27.9427.2828.7248.9855.7749.58
Total Liabilities
1,1771,2401,080917.32913.1850.43
Common Stock
621.92623.71511.14510.4504504
Additional Paid-In Capital
1,0881,098651.74478.34462.06462.06
Retained Earnings
2,0822,0732,0952,0251,9581,888
Treasury Stock
--6.77-26.99-23.62--
Comprehensive Income & Other
0.243.093.424.173.293.29
Total Common Equity
3,7923,7913,2342,9942,9282,857
Minority Interest
1,0551,0571,178632.88606.84575.68
Shareholders' Equity
4,8474,8494,4123,6273,5353,433
Total Liabilities & Equity
6,0246,0895,4934,5444,4484,284
Total Debt
190.29189.2141.675.316.66-
Net Cash (Debt)
2,3692,4532,0771,8321,4861,317
Net Cash Growth
12.68%18.08%13.39%23.26%12.85%-16.44%
Net Cash Per Share
3.834.144.123.642.952.61
Filing Date Shares Outstanding
621.92623.71629.06488.88510.4504
Total Common Shares Outstanding
621.92623.71511.14488.88504504
Working Capital
2,5832,5912,0071,7681,4331,248
Book Value Per Share
6.106.086.336.125.815.67
Tangible Book Value
3,4073,4032,7442,7082,7692,645
Tangible Book Value Per Share
5.485.465.375.545.505.25
Buildings
-1,4951,5071,2941,2741,304
Machinery
-1,4161,3491,1141,0741,014
Construction In Progress
-71.7884.237.8428.7816.56
Source: S&P Global Market Intelligence. Standard template. Financial Sources.